Department of Medical Social Sciences, Northwestern University, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.
Department of Pediatrics, University of North Carolina, Chapel Hill, NC 27599, USA; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.
Patient Educ Couns. 2021 Dec;104(12):2989-2998. doi: 10.1016/j.pec.2021.04.026. Epub 2021 Apr 29.
Many people prefer to learn secondary or "additional" findings from genomic sequencing, including findings with limited medical actionability. Research has investigated preferences for and effects of learning such findings, but not psychosocial and behavioral effects of receiving education about them and the option to request them, which could be burdensome or beneficial (e.g., causing choice overload or satisfying strong preferences, respectively).
335 adults with suspected genetic disorders who had diagnostic exome sequencing in a research study and were randomized to receive either diagnostic findings only (DF; n = 171) or diagnostic findings plus education about additional genomic findings and the option to request them (DF + EAF; n = 164). Assessments occurred after enrollment (Time 1), after return of diagnostic results and-for DF + EAF-the education under investigation (Time 2), and three and six months later (Times 3, 4).
Time 2 test-related distress, test-related uncertainty, and generalized anxiety were lower in the DF + EAF group (ps = 0.025-0.043). There were no other differences.
Findings show limited benefits and no harms of providing education about and the option to learn additional findings with limited medical actionability.
Findings can inform recommendations for returning additional findings from genomic sequencing (e.g., to research participants or after commercial testing).
许多人希望了解基因组测序的次要或“附加”发现,包括那些具有有限医学可操作性的发现。研究已经调查了对这些发现的偏好及其影响,但没有研究接受这些发现的教育以及请求这些发现的选择的心理社会和行为影响,这些影响可能是负担,也可能是有益的(例如,分别导致选择过载或满足强烈偏好)。
335 名疑似遗传疾病的成年人在一项研究中进行了诊断外显子组测序,并被随机分配接受仅诊断结果(DF;n=171)或诊断结果加上关于附加基因组发现的教育和请求这些发现的选择(DF+EAF;n=164)。评估在入组后(时间 1)、诊断结果返回后(DF+EAF 组还在接受调查的教育后)以及三个月和六个月后进行(时间 3、4)。
DF+EAF 组在时间 2 的测试相关困扰、测试相关不确定性和广泛性焦虑较低(p=0.025-0.043)。没有其他差异。
研究结果表明,提供关于具有有限医学可操作性的附加发现的教育和选择学习这些发现的益处有限,没有危害。
研究结果可以为提供基因组测序的附加发现提供建议(例如,提供给研究参与者或商业测试后)。